Region Stockholm – SLSO

Research activity includes studies in major depressive disorder, with a focus on depressive symptoms in people affected by cancer. The sponsor also supports work involving psilocybin for cancer-related depression.

  • Major depressive disorder
  • Cancer-related depression
  • Psilocybin

Interest in this area extends to symptom relief and mental health outcomes in patients with serious medical illness.

Pain and fibromyalgia

The sponsor funds research in fibromyalgia, particularly autoantibody-mediated disease and chronic pain management. This includes clinical interest in reducing daily pain burden and understanding immune-linked pain conditions.

  • Fibromyalgia
  • Chronic pain
  • Autoantibody-mediated disease

These studies reflect a therapeutic focus on pain syndromes with possible inflammatory or immune mechanisms.

Metabolic disease and vaccinology

Clinical research activity covers obesity and type 2 diabetes, alongside studies of immune response to influenza vaccination in people with excess body weight. The sponsor’s portfolio also includes work on vaccine immunogenicity and protective antibody responses.

  • Obesity
  • Type 2 diabetes
  • Influenza vaccination

Additional interest lies in how metabolic status influences vaccine-induced immunity.

Neurology and neurodegenerative disease

The sponsor supports trials in Parkinson’s disease, with attention to disease progression, motor symptoms, and biologic pathways in the brain. Research also includes treatment-related effects relevant to long-term neurological care.

  • Parkinson’s disease
  • Motor symptoms
  • Neurodegeneration

This area reflects a strong interest in therapies that address both symptomatic control and progression of neurological disease.

Infectious diseases and neuroinflammation

Current research includes influenza and tick-borne encephalitis, with emphasis on immune protection and neurological injury during viral infection. The sponsor also studies antiviral treatment in TBE and related markers of neuronal damage.

  • Influenza
  • Tick-borne encephalitis
  • Neuronal injury

These studies span prevention and treatment questions in viral illness with neurological complications.

Want to learn more about this study or check if you can participate? Contact us.

Matched clinical trials

  • Study on How Exenatide Affects Early Parkinson’s Disease Progression in Patients

    Recruiting

    2 1 1
    Investigated diseases:
    Investigated drugs:
    Sweden
  • Randomized Study of Tolebrutinib Versus Rituximab in Adults with Multiple Sclerosis

    Not yet recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    Sweden
  • Study of rituximab for reducing pain in patients with fibromyalgia caused by autoantibodies

    Not yet recruiting

    3 1 1 1
    Investigated diseases:
    Sweden
  • Testing Remdesivir in Hospitalized Adult Patients with Tick-Borne Encephalitis to Measure Effects on Brain Cell Damage

    Not yet recruiting

    2 1 1
    Investigated drugs:
    Sweden
  • Testing the Immune Response to Trivalent Inactivated Influenza Vaccine in People with Obesity and Type 2 Diabetes

    Not yet recruiting

    3 1 1 1
    Investigated diseases:
    Sweden
  • Study on Psilocybin for Treating Depression in Cancer Patients

    Not yet recruiting

    2 1 1
    Investigated diseases:
    Sweden